Insamo Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Insamo General Information

Description

Operator of a biotechnology company intended to pioneer the discovery of membrane-permeable and orally available cyclic peptides with antibody-like binding affinity. The company develops molecular biology and parallel synthetic chemistry to rapidly identify preclinical candidates that exhibit favorable pharmacological properties, enabling health professionals to enhance patient care by replacing injected or infused biologics with easily administered oral cyclic-peptide formulations.

Contact Information

Website
www.insamo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2630 Bancroft Way
  • Berkeley, CA 94704
  • United States
+1 (201)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 2630 Bancroft Way
  • Berkeley, CA 94704
  • United States
+1 (201)

Insamo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Insamo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 02-Apr-2024 Completed Startup
2. Seed Round 21-Feb-2024 Completed Startup
1. Seed Round 20-Mar-2023 $9.5M $9.5M Completed Startup
To view Insamo’s complete valuation and funding history, request access »

Insamo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Insamo’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Insamo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Insamo Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axial (San Francisco) Venture Capital Minority
BEVC (Berkeley) Venture Capital Minority
Civilization Ventures Venture Capital Minority
MRL Ventures Fund Corporate Venture Capital Minority
Playground Global Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Insamo FAQs

  • When was Insamo founded?

    Insamo was founded in 2022.

  • Where is Insamo headquartered?

    Insamo is headquartered in Berkeley, CA.

  • What is the size of Insamo?

    Insamo has 15 total employees.

  • What industry is Insamo in?

    Insamo’s primary industry is Biotechnology.

  • Is Insamo a private or public company?

    Insamo is a Private company.

  • What is Insamo’s current revenue?

    The current revenue for Insamo is .

  • How much funding has Insamo raised over time?

    Insamo has raised $21.5M.

  • Who are Insamo’s investors?

    Axial (San Francisco), BEVC (Berkeley), Civilization Ventures, MRL Ventures Fund, and Playground Global are 5 of 7 investors who have invested in Insamo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process